LINCOLNTON, N.C., April 2, 2021 /PRNewswire/ -- Annihilare Medical Systems Incorporated ("Annihilare") announced today that it has ended all supplemental distribution agreements for its disinfectant product Annihilyte® (EPA Reg. No. 92449-1), and will focus on bringing its bottling capability in-house exclusively.
Read the full article here: